TARDBP and amyotrophic lateral sclerosis: MNs from patients with TARDBP mutations have increased levels of soluble and detergent‐resistant TDP‐43 and show decreased cell survival, suggesting that this model is representative for ALS pathology (Bilican et al., 2012; Fujimori et al., 2018).